COMPOSÉS CO-AGONISTES GIP ET GLP-1
- 专利权人:
- Eli Lilly and Company
- 发明人:
- 申请号：
- EP19188718.1
- 公开号：
- EP3597662A1
- 申请日:
- 2016.01.05
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to dual incretin peptide mimetic compounds that agonize receptors for both human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and may be useful for treating type 2 diabetes mellitus (T2D).
- 来源网站：
- 中国工程科技知识中心
